Pipeline
Pharos Vaccine creates veterinary vaccines by developing highly efficient and safe vaccine proteins based on our excellent protein engineering technology.
Vaccines using proteins as immunogens can fundamentally exclude the risks from live pathogens, such as viruses, in virus-based vaccines, and can rapidly correspond to variations and mutations of pathogens to efficiently tackle altered diseases.
Also, Pharos Vaccine is putting effort into developing immunological treatments and immunotherapies for animals based on our understanding of the human immune system and research experience.
FMD Vaccine
Development of immunogen
Development of formulations
Efficacy and safety test
Clinical trial (field)
Approval
Launching
PED Vaccine
Development of immunogen
Development of formulations
Efficacy and safety test
Clinical trial (field)
Approval
Launching
PharoIC
Development of immunogen
Development of formulations
Efficacy and safety test
Clinical trial (field)
Registration
Launching
Canine Immune Cell Therapy
Development of immunogen
Development of formulations
Efficacy and safety test
Clinical trial
Approval
Launching